Organization Profile

You just read:

OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters

News provided by

OncoGenex Pharmaceuticals, Inc.

Mar 23, 2012, 09:00 ET